Literature DB >> 18036102

Treatment of chronic portosystemic encephalopathy in cirrhotic patients by embolization of portosystemic shunts.

Sémia H Zidi1, David Zanditenas, Moana Gelu-Siméon, Anne-Sophie Rangheard, Dominique C Valla, Valérie Vilgrain, Gilles M Pelletier.   

Abstract

UNLABELLED: AIMS/BACKGROUNDS: Large spontaneous portal-systemic shunts can occasionally be the cause of chronic and disabling encephalopathy in cirrhotic patients. Shunt embolization has been proposed, however the clinical relevance of this technique remains uncertain. METHODS/
RESULTS: We report our results in seven patients treated by shunt embolization. Although the procedure was achieved and technically successful in all patients, the clinical results were poor as long-term improvement was obtained in only one patient. Three patients died within 3 months after the procedure from cirrhoses' end stage complications.
CONCLUSION: We believe that optimal management of these patients with chronic spontaneous encephalopathy is liver transplantation.

Entities:  

Mesh:

Year:  2007        PMID: 18036102     DOI: 10.1111/j.1478-3231.2007.01602.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  9 in total

1.  Atypical use of ALN inferior vena cava filters as protection devices prior to embolization of a large portosystemic shunt with Amplatzer Vascular Plugs and Glubran 2 cyanoacrylate glue.

Authors:  Pierre-Emmanuel Berthod; Olivier Chevallier; Marianne Latournerie; Sophie Gehin; Nicolas Falvo; Marco Midulla; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2018-05

Review 2.  Portosystemic shunt syndrome and endovascular management of hepatic encephalopathy.

Authors:  Wael E Saad
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

3.  Shunt occlusion for portosystemic shunt syndrome related refractory hepatic encephalopathy-A single-center experience in 21 patients from Kerala.

Authors:  Cyriac Abby Philips; Lijesh Kumar; Philip Augustine
Journal:  Indian J Gastroenterol       Date:  2017-11-10

4.  Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy.

Authors:  Amanda M Lynn; Siddharth Singh; Stephen E Congly; Disha Khemani; David H Johnson; Russell H Wiesner; Patrick S Kamath; James C Andrews; Michael D Leise
Journal:  Liver Transpl       Date:  2016-06       Impact factor: 5.799

5.  Proximal total splenic artery embolization for refractory hepatic encephalopathy.

Authors:  Harufumi Maki; Junichi Kaneko; Junichi Arita; Nobuhisa Akamatsu; Yoshihiro Sakamoto; Kiyoshi Hasegawa; Sumihito Tamura; Hidemasa Takao; Eisuke Shibata; Norihiro Kokudo
Journal:  Clin J Gastroenterol       Date:  2017-12-01

Review 6.  Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options.

Authors:  Saleh Elwir; Robert S Rahimi
Journal:  J Clin Transl Hepatol       Date:  2017-05-04

7.  Intractable Hepatic Encephalopathy with a Large Portosystemic Shunt Successfully Treated Using Shunt-preserving Disconnection of the Portal and Systemic Circulation.

Authors:  Masafumi Haraguchi; Satoshi Hirai; Yutaka Nakamura; Tetsuhiro Otsuka; Hideki Ishimaru; Ryu Sasaki; Masanori Fukushima; Satoshi Miuma; Hisamitsu Miyaaki; Kazuhiko Nakao
Journal:  Intern Med       Date:  2020-02-01       Impact factor: 1.271

8.  Selective embolization of the splenic vein for shunt-preserving disconnection of the portal and systemic circulation: report of two cases.

Authors:  Osamu Ikeda; Yutaka Nakasone; Toru Beppu; Toshiro Masuda; Hideo Baba; Yasuyuki Yamashita
Journal:  Acta Radiol Short Rep       Date:  2012-08-31

Review 9.  Hepatic encephalopathy: early diagnosis in pediatric patients with cirrhosis.

Authors:  Naghi Dara; Ali-Akbar Sayyari; Farid Imanzadeh
Journal:  Iran J Child Neurol       Date:  2014
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.